Floatz logo

Allopurinol

Blastic Phase Chronic Myelogenous Leukemia

Roswell Park Cancer InstituteSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

43 Active assets in the Blastic Phase Chronic Myelogenous Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
Ohio State University Comprehensive Cancer Center
Phase 2BBB
TACROLIMUS
University of Michigan Rogel Cancer Center
Phase 2BB
Imatinib
The University of Hong Kong
Phase 2BB
METHOTREXATE
University of Michigan Rogel Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Allopurinol is also rated in:

manic bipolar affective disorderDormant
BB
Indicative ·
70 / 100
View asset →
Untreated Adult Acute Lymphoblastic LeukemiaDormant
BB
Indicative ·
68 / 100
View asset →
essential hypertensionDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →